| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 11.293 | - | - | 0 | 0 | - | - | - | - | - |
| Total Income - EUR | 12.103 | - | - | 0 | 2.107 | - | - | - | - | - |
| Total Expenses - EUR | 8.817 | - | - | 4.509 | 0 | - | - | - | - | - |
| Gross Profit/Loss - EUR | 3.286 | - | - | -4.509 | 2.107 | - | - | - | - | - |
| Net Profit/Loss - EUR | 2.923 | - | - | -4.509 | 2.044 | - | - | - | - | - |
| Employees | 0 | - | - | 0 | 0 | - | - | - | - | - |
Check the financial reports for the company - Pharma Vision Intermediate Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 9.078 | - | - | 0 | 0 | - | - | - | - | - |
| Current Assets | 27.068 | - | - | 25.390 | 27.005 | - | - | - | - | - |
| Inventories | 0 | - | - | 0 | 0 | - | - | - | - | - |
| Receivables | 1.743 | - | - | 1.287 | 1.262 | - | - | - | - | - |
| Cash | 25.325 | - | - | 24.103 | 25.743 | - | - | - | - | - |
| Shareholders Funds | 34.973 | - | - | 24.735 | 26.300 | - | - | - | - | - |
| Social Capital | 90 | - | - | 86 | 84 | - | - | - | - | - |
| Debts | 774 | - | - | 273 | 331 | - | - | - | - | - |
| Income in Advance | 0 | - | - | 0 | 0 | - | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Pharma Vision Intermediate Srl